Oskar Hansson
Physiology · 2002–2023
A researcher in the Science corpus: 17 papers; trusts 6 researchers and is trusted by 2 researchers here, as inferred from the citation graph.
Subfields
- Physiology — 130 citations into it; #1,309 of 2,276 by trust here, #392 by citations
- Psychiatry and Mental health — 114 citations into it; #829 of 1,338 by trust here, #126 by citations
- Neurology — 50 citations into it; #1,059 of 1,455 by trust here, #225 by citations
- Molecular Biology — 43 citations into it
- Pharmacology — 14 citations into it
- Public Health, Environmental and Occupational Health — 7 citations into it
Whom Oskar Hansson trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Oskar Hansson overall
Papers from Oskar Hansson's perspective
Ordered by how strongly the researchers Oskar Hansson trusts endorse each paper. Same corpus, a different order for every researcher.
- Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade (Lancet Neurology)
- Criteria for the diagnosis of corticobasal degeneration (Neurology)
- Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives (Nature reviews. Drug discovery)
- Current concepts in mild cognitive impairment. (Archives of Neurology)
- Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. (Lancet Neurology)
- Mild cognitive impairment as a diagnostic entity (Journal of Internal Medicine)
- Practical statistics for medical research
- Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment (Journal of Internal Medicine)
- Multi-modal techniques for diagnosis and prognosis of Alzheimer’s disease (Nature)
- Research criteria for subcortical vascular dementia in clinical trials. (Journal of neural transmission. Supplementum)
Their papers
- Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease. (2002) — 639 citations
- Blood-based biomarkers for Alzheimer's disease: towards clinical implementation. (2021) — 800 citations
- Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets (2023) — 622 citations
- Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial. (2023) — 2,216 citations
- Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer’s Disease (2022) — 1,144 citations
- Brain charts for the human lifespan (2021) — 1,503 citations
- Biomarkers for neurodegenerative diseases (2021) — 765 citations
- Four distinct trajectories of tau deposition identified in Alzheimer’s disease (2021) — 636 citations
- Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. (2020) — 1,081 citations
- Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia (2020) — 1,061 citations
- Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders. (2020) — 1,288 citations
- Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis. (2019) — 678 citations
- CSF biomarkers of Alzheimer’s disease concord with amyloid-β PETand predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts (2018) — 715 citations
- Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity (2017) — 834 citations
- Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia. (2012) — 656 citations
- CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. (2009) — 1,205 citations
- Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. (2006) — 1,711 citations